RecruitingNCT05743569

3D Specimen Maps for RT Planning

Virtual Patient-specific 3D Specimen Maps for Adjuvant Head & Neck Radiotherapy Planning

Sponsor

Vanderbilt University Medical Center

Enrollment

13 participants

Start Date

Jan 26, 2023

Study Type

OBSERVATIONAL

Conditions

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Radiation Therapy

Summary

The primary objective of this study is to measure the impact of patient-specific 3D specimen maps on adjuvant radiation treatment volumes and doses to critical organs. All patients will receive standard-of-care post-operative radiotherapy not impacted by the experimental 3D specimen maps. The secondary objective is to demonstrate the feasibility of incorporating 3D specimen mapping tools into post-operative communication, and to determine if utilization of the 3D specimen map improves post-operative communication between surgeons, pathologists, and radiation oncologists.

Eligibility

Min Age: 28 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether detailed 3D maps of surgically removed head and neck cancer specimens can help radiation oncologists more precisely plan post-operative radiation therapy, potentially reducing damage to healthy tissue while ensuring the cancer area is fully treated. **You may be eligible if...** - You are over 18 years old - You have a confirmed head and neck cancer (mucosal type) in areas such as the oral cavity, throat, voice box, or pharynx - You have already completed surgery to remove the primary tumor - You have consented to 3D specimen mapping under a linked protocol - You are scheduled to receive post-surgical radiation therapy at Vanderbilt University Medical Center or affiliated sites **You may NOT be eligible if...** - You are under 18 years old - Your cancer is a skin cancer (cutaneous malignancy) - You have characteristics that make informed consent difficult - You are pregnant - You have medical reasons that prevent you from receiving radiation therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.